ChatGPT helped 27-year-old woman identify cancer symptoms before doctors did; here's how AI came to her rescue
Marly had been suffering from continuous night sweats and skin irritation but thought these were stress-related reactions after the death of her father due to colon cancer. Medical checkups at the time didn't reveal any serious health concern, with test results showing back normal.
She chose to share her symptoms with ChatGPT seeking answers. The AI chatbot replied by indicating that she could be exhibiting signs of blood cancer, a suggestion she initially dismissed. The woman informed People.com that she didn't take the chatbot's advice seriously, and her friends also advised her not to trust a machine for medical guidance.
Marley started to feel drained frequently and observed pain in her chest. A second round of medical consultations led to a scan, which disclosed a 'big mass' in her left lung. Doctors diagnosed her with Hodgkin lymphoma, a rare type of blood cancer that impacts the white blood cells.
She says she never believed an AI tool would recognise something so critical before medical systems get their attention on. 'I just didn't want my family to go through this all over again,' she said shockingly.
Although rare, Hodgkin lymphoma has a relatively high recovery rate when detected early. Health experts say the five-year survival rate exceeds 80% . Common symptoms consist of fatigue, abdominal pain, itchy skin, night sweats and fever — many of which Marley endured. As she continues with her treatment, she hopes her story inspires others to trust their instincts and seek additional opinions when something feels off.
'It's really important to listen to our bodies. Sometimes we tend to lose our connection with our inner self,' The Daily Mail quoted her as saying.
Hodgkin lymphoma, which is rarer than non-Hodgkin Lymphoma, is treatable, according to the Cleveland Clinic, with the lowest rate of survival being 81% after five years. Symptoms comprise itchy skin and night sweats, as well as abdominal pain, fever, and fatigue. Marley said she's 'confident for the future,' and wants to warn others to advocate for themselves.
Although ChatGPT is not a substitute for medical advice, Marley's experience contributes to the ongoing discussion about how AI could assist in early symptom recognition, particularly in cases where traditional diagnoses may take time.
First Published: 27 Apr 2025, 10:18 AM IST
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
3 hours ago
- Time of India
How ChatGPT cured him of financial anxiety? Entrepreneur and best-selling author explains
Adrian Brambila , a renowned entrepreneur and best-selling author, recently captured widespread attention online when he revealed how artificial intelligence helped him navigate personal finance challenges. Faced with growing uncertainty about his financial situation, Brambila decided to test a new approach—one that involved using ChatGPT to build a personalized money management system . Instead of relying on complex budgeting tools, expensive advisors, or spreadsheet-heavy methods, he shared his income details with ChatGPT and asked it to map out a clear financial routine. In just a handful of prompts, he found himself with a solid framework that eliminated confusion and brought structure to his financial decisions. The system not only simplified his monthly planning but also gave him a newfound sense of empowerment over his money. Explore courses from Top Institutes in Please select course: Select a Course Category Healthcare Data Analytics Digital Marketing Leadership Public Policy Finance PGDM Management MBA Artificial Intelligence Data Science Others Project Management Cybersecurity Data Science MCA CXO Technology Design Thinking others Degree healthcare Operations Management Product Management Skills you'll gain: Financial Analysis in Healthcare Financial Management & Investing Strategic Management in Healthcare Process Design & Analysis Duration: 12 Weeks Indian School of Business Certificate Program in Healthcare Management Starts on Jun 13, 2024 Get Details Brambila's strategy revolved around a zero-based budgeting method where every rupee was assigned a role. He split his monthly earnings using the 50/30/20 approach—half going toward essential expenses, 30 percent for lifestyle-related purchases, and the remaining 20 percent saved or used to pay off debt. This allowed his financial habits to match his daily needs and long-term goals without unnecessary complexity. He then crafted a personalized cash flow tracker with ChatGPT's assistance, giving him a real-time snapshot of his earnings and spending. The AI also helped set monthly savings benchmarks linked directly to his aspirations, ensuring his finances worked in service of his dreams rather than becoming a source of stress. To maintain consistency, he developed a short weekly check-in process that helped reinforce positive habits. He even asked ChatGPT to outline a basic, easy-to-follow investment plan aimed at beginners. The goal wasn't to build a cutting-edge financial empire, but to design a repeatable, low-tech system that brought consistency and calm into his financial life. Brambila emphasized that the greatest benefit wasn't just better budgeting—it was the peace of mind that came with finally understanding and organizing his finances. He credited AI with transforming a complicated part of adult life into something manageable and even empowering. Among the most impactful tools he used was the 50/30/20 guideline. This rule created balance by allocating income into three broad categories: essential needs like housing and groceries (50%), discretionary spending such as dining or leisure (30%), and savings or debt repayments (20%). It offered a structured yet adaptable way to manage money without rigid line-by-line breakdowns. His story sparked wide-ranging responses online. While some were intrigued by the potential of AI in personal finance, others raised concerns about data privacy and questioned whether artificial intelligence could one day replace human financial experts. Who Is Adrian Brambila? According to information available on his LinkedIn profile, Adrian Brambila is a digital business owner who previously had a career as a professional dancer before transitioning into a prominent figure in online marketing. Boasting a combined following of more than 1.7 million across various social media platforms, Adrian's rise to prominence followed a unique and unconventional path. During the COVID-19 pandemic, he adopted a minimalist lifestyle by residing in a van while journeying throughout the United States. Throughout his travels, he regularly shared his day-to-day experiences, highlighting how he managed to earn more than $100,000 every month through internet-based income sources. His content illustrated the powerful balance between financial abundance and living simply, proving that prosperity doesn't require excess. Adrian is also the founder of two entrepreneurial ventures: a digital marketing resource, and a platform offering strategies for building wealth online. In addition to his entrepreneurial projects, he authored the book Start Thinking Rich, in which he presents his philosophies on mindset, digital entrepreneurship, and redefining success through intentional living.
Time of India
a day ago
- Time of India
‘ChatGPT helped me lose 27 kilos in 6 months': Man says after life-changing AI transformation
What started as a digital experiment turned into a radical health transformation for a YouTuber known for his channel My Life By AI. In a video posted on July 12, 2025, he revealed how using ChatGPT as a personal assistant helped him shed 27 kilograms (about 60 pounds) and regain control of his physical and mental well-being. Powered by a virtual AI coach he named Arthur, the six-month journey was driven by discipline, smart planning, and daily guidance from OpenAI's chatbot. He credits the system for rebuilding his health and his life. How AI helped break bad habits and build a weight loss routine Rather than using ChatGPT for simple queries, the YouTuber integrated it into his entire lifestyle, creating a virtual assistant named Arthur to manage everything from meals and workouts to his creative workflow. Initially, his weekends were filled with fast food indulgences—burgers, fries, beer—leading to guilt and setbacks. But with Arthur's daily check-ins, tailored exercise prompts, and AI-generated strategies like post-meal walks and craving substitutions, he gradually replaced those patterns with healthier also planned structured, nutritious meals and offered consistency he had long lacked. Over time, this AI-guided system transformed his health, mindset, and routine, proving crucial to his 27-kilo weight loss journey. What's on the plate: Clean, AI-guided eating Using ChatGPT, he replaced processed snacks with whole foods and balanced meals. His daily diet included: Breakfast: Scrambled eggs with Parmesan and toast Lunch: Chili beef, rice, and refried beans Dinner: Baked chicken, sweet kumara, grilled capsicum and courgettes, finished with Greek yogurt This AI-assisted meal planning ensured both nutrition and satiety without guesswork. Consistency Over Perfection 'The goal wasn't to be perfect. It was to be consistent,' he said. This mindset, reinforced by Arthur, helped him stick to his routine even on tough days. Whether it was walking several kilometers or logging meals, the AI system reduced decision fatigue and helped create long-term habits. Aside from the physical transformation, the man described notable improvements in energy, mood, and focus. The AI didn't just offer instructions. It became a support system. By reducing mental clutter, Arthur gave him space to be more present, creative, and resilient. For this YouTuber, AI isn't just a productivity tool. It is a lifestyle enabler. 'Letting AI run my life didn't make me perfect. But it made me consistent,' he said. His story offers a glimpse into a future where personal health, productivity, and wellness may be deeply intertwined with digital intelligence.
Time of India
2 days ago
- Time of India
Zydus Life's plans for cancer biosimilar hit a legal hurdle
Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Mumbai: The Delhi High Court has issued an interim injunction against Ahmedabad-based drug maker Zydus Lifesciences after a case filed by the US pharma giant Bristol Myers Squibb alleging patent infringement on its blockbuster anticancer drug Opdyta nivolumab ) branded as Opdivo in other restraining order comes as a setback for the Indian drug maker which was running clinical trials in India for the launch of the biosimilar versions of nivolumab. The earliest patent for the drug expires in India on May 2, 2026. The next hearing for the case is August 101-page order issued on July 18 by Justice Mini Pushkarna ruled that the defendants, and all others acting on its behalf, are restrained from manufacturing, using, selling, offering for sale, importing, exporting, advertising, or dealing in any biosimilar/similar biologic of nivolumab, the suit patent, during the pendency of the present suit. The order stated the plaintiffs shall suffer irreparable loss, in case the interim relief as prayed for, was not injections are one of the many latest generation immunotherapy drugs also known as checkpoint inhibitors increasingly used to treat several types of cancers including skin, lungs, kidneys, and Hodgkin lymphoma. It works by activating the body's T-cells or immune cells by targeting a protein called PD-1, thereby unleashing an attack on the cancer vials are sold in India for roughly '2 lakh but for patients who are part of the company's assistance or access programs, the drug is available at a slab-wise discounted the India data is not available, globally Bristol Myers Squibb recorded Opdivo sales of $9.3 billion in 2024. Indian companies have launched biosimilars at half the cost of those charged by their global in Indian patent laws told ET that the court has taken a view that stockpiling of a product during its active patent life amounts to infringement and to release it or flood the market is not legally valid."This opinion may have implications for the other ongoing disputes like the weight-loss drug semaglutide (branded Wegovy) case between Novo Nordisk and Dr. Reddy's Labs or Roche versus Natco for Risdiplam (drug used for a rare disease called spinal muscular atrophy or SMA) case," a senior lawyer petition from BMS noted that Zydus Lifesciences was conducting clinical trials for nivolumab and on its investigation found that the company had plans to launch it during the patent period. The Indian company, it said, had applied for a marketing approval with the central drug regulatory its part, lawyers on behalf of Zydus defended saying its product ZRC-3276 does not infringe upon the existing patents and is following the regulatory was represented by a battery of top lawyers including Harish Salve, Dushyant Dave, and Rajiv Nayar, while Squibb & Sons was represented by Sandeep Sethi, PS Raman, Amit Sibal and Pravin Anand, among others.
